Sai Phytoceuticals

New Delhi, India Founded: 2002 • Age: 24 yrs
Manufactures plant-based anti-cancer products, phytoceuticals, and APIs for domestic and international markets.
Annual revenue $1.3M Latest available
Total funding - Funding intelligence
Employees 34 Tracked headcount
Investors - Known backers
Products 6 Services tracked
Competitors - Brand Intelligence

About Sai Phytoceuticals

Sai Phytoceuticals is a company based in New Delhi (India) founded in 2002. It operates as a B2B. The company has 34 employees as of March 31, 2023. Sai Phytoceuticals offers products and services including PACLITAXEL, CABAZITAXEL, CARFILZOMIB, ETOPOSIDE, and DEHYDROEPIANDROSTERONE.

  • Headquarter New Delhi, India
  • Employees 34 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Sai Phytoceuticals Private Limited
  • Date of Incorporation 23 Jun, 1995
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.26 M (USD)
    146.96
    as on Mar 31, 2023
  • Net Profit
    $46.29 K (USD)
    94.05
    as on Mar 31, 2023
  • EBITDA
    $126.15 K (USD)
    118.4
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    34

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sai Phytoceuticals

Sai Phytoceuticals offers a comprehensive portfolio of products and services, including PACLITAXEL, CABAZITAXEL, CARFILZOMIB, ETOPOSIDE, and DEHYDROEPIANDROSTERONE.

Product name locked
Category locked
Primary

Anti-cancer drug used in chemotherapy for treating various cancers.

Product name locked
Category locked
Locked

Medication for advanced prostate cancer in pharmaceutical treatments.

Product name locked
Category locked
Locked

Proteasome inhibitor for multiple myeloma cancer therapy.

Product name locked
Category locked
Locked

Chemotherapy agent targeting lung and testicular cancers.

Product name locked
Category locked
Locked

Hormone precursor used in synthetic pharmaceutical intermediates.

Product name locked
Category locked
Locked

Natural compound for steroid API production in drugs.

Funding Insights of Sai Phytoceuticals

Premium access

Detailed funding history for Sai Phytoceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sai Phytoceuticals

Investments
Premium access

Investment portfolio details for Sai Phytoceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sai Phytoceuticals

Premium access

Detailed financials for Sai Phytoceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sai Phytoceuticals Comparisons

Sai Phytoceuticals Primary company
Description
Manufactures plant-based anti-cancer products, phytoceutical...
Location
New Delhi, India
Founded Year
2002
Annual Revenue
$1.26 M (USD)
Net Profit
$46.29 K (USD)
EBITDA
$126.15 K (USD)
Employees
34
As of 2023
Premium access

Peer comparison for Sai Phytoceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sai Phytoceuticals

Premium access

Detailed competitors of Sai Phytoceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sai Phytoceuticals

Premium access

Complete news archive for Sai Phytoceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Phytoceuticals

Sai Phytoceuticals was founded in 2002.

Sai Phytoceuticals is headquartered in New Delhi, India. It is registered at New Delhi, Delhi, India.

As of Mar 31, 2023, the latest employee count at Sai Phytoceuticals is 34.

Annual revenue of Sai Phytoceuticals is $1.26M as on Mar 31, 2023.

Sai Phytoceuticals is a certified company established in 2002, focusing on manufacturing and marketing plant-based products such as oncology APIs, steroid intermediates, and custom synthesized compounds. It operates in the pharmaceutical sector, producing items like Paclitaxel and Cabazitaxel for anti-cancer applications. The company serves both domestic and international markets through B2B channels. Its facilities are located in New Delhi and Bhind, India, ensuring compliance with ISO and GMP standards. Clients include various pharmaceutical entities requiring specialized intermediates.

Sai Phytoceuticals offers PACLITAXEL, CABAZITAXEL, CARFILZOMIB, ETOPOSIDE, and 2 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available